Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Francesco Mirenghi"'
Autor:
Claudia, Altobelli, Emanuela, de Pascale, Gabriella, Di Natale, Gaia, Marinelli, Maristella, Minco, Francesco, Mirenghi, Roberta, Russo, Corrado, Pluvio
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 38(3)
SARS-CoV-2 infection is responsible for the coronavirus disease 2019 (COVID-19). In the complex scenario of COVID-19, it is also possible to find patients with renal damage. The pathogenesis is multifactorial and not unique, and the clinical presenta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1848a6a0d4e8b6f9f35d5435601129fc
https://pubmed.ncbi.nlm.nih.gov/34169691
https://pubmed.ncbi.nlm.nih.gov/34169691
Publikováno v:
The Lens
Differentiation syndrome (DS), previously known as retinoic acid syndrome or ATRA (all-trans retinoic acid) or ATO (arsenic trioxide) syndrome, is a life-threatening complication of the therapy with differentiating agents in patients with acute promy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1f34c5a7428028918e9a65d2e94e7400
https://pubmed.ncbi.nlm.nih.gov/31373469
https://pubmed.ncbi.nlm.nih.gov/31373469
Autor:
Domenico Russo, Luigi Russo, Francesco Mirenghi, Biagio Di Iorio, Lucia Di Micco, Serena Torraca, Maria Luisa Sirico, Andrea Pota
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 7(4)
Summary Background and objectives High levels of fibroblast growth factor 23 are associated with mortality, CKD progression, and calcification in CKD patients. The aim of this pilot study is to assess whether a very-low-protein diet (0.3 g/kg per day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86351376e99bf04b1eadae5bc59b1a8
https://pubmed.ncbi.nlm.nih.gov/22362063
https://pubmed.ncbi.nlm.nih.gov/22362063
Autor:
Juan F. Navarro, Annalisa Ragosta, Stefano Federico, Francesco Mirenghi, Antonio Cesaro, Rinaldo Bellomo, Hiroshi Morimatsu, Victoria E. García-Rodríguez, Shigehiko Uchino, Margarita Monge, Philip N. Hawkins, Massimo Sabbatini, Anna Crispo, Andrew Davenport, Ian T. Baldwin, Antonio Pisani, José R. Weisinger, Víctor García-Nieto, Nigel Fealy, Helen J. Lachmann, Bruno Cianciaruso
Publikováno v:
Nephron Clinical Practice. 94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b8ca66293a1cd6ed429bbd7ad18cd2d
https://doi.org/10.1159/000073462
https://doi.org/10.1159/000073462
Autor:
Stefano Federico, Antonio Pisani, Annalisa Ragosta, Anna Crispo, Bruno Cianciaruso, Francesco Mirenghi, Antonio Cesaro, Massimo Sabbatini
Background/Aim: A recent survey has shown that insomnia is still a very common problem in maintenance hemodialysis (MHD) patients. The aim of the present study was to test the effects of zaleplon (ZAL), a new nonbenzodiazepine hypnotic drug, on the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c798582aab4d7298ad4502e0d57f7a7e
http://hdl.handle.net/11588/345400
http://hdl.handle.net/11588/345400
